Round Angle Advisors LLC Ocular Therapeutix, Inc Transaction History
Round Angle Advisors LLC
- $129 Billion
- Q3 2025
A detailed history of Round Angle Advisors LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Round Angle Advisors LLC holds 176,800 shares of OCUL stock, worth $2.08 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
176,800
Previous 185,706
4.8%
Holding current value
$2.08 Million
Previous $1.72 Billion
19.93%
% of portfolio
1.6%
Previous 1.44%
Shares
4 transactions
Others Institutions Holding OCUL
# of Institutions
204Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$168 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$164 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$150 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$136 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$98.9 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $907M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...